YD Bio Limited (NASDAQ:YDES – Get Free Report)’s stock price was up 9.8% on Friday . The stock traded as high as $2.44 and last traded at $2.24. 83,139 shares traded hands during mid-day trading, a decline of 74% from the average daily volume of 322,873 shares. The stock had previously closed at $2.04.
YD Bio Trading Up 9.8%
The stock’s 50-day simple moving average is $2.89 and its 200-day simple moving average is $6.43.
Hedge Funds Weigh In On YD Bio
An institutional investor recently raised its position in YD Bio stock. Geode Capital Management LLC increased its stake in YD Bio Limited (NASDAQ:YDES – Free Report) by 10.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the period. Geode Capital Management LLC owned 0.08% of YD Bio worth $711,000 at the end of the most recent reporting period.
YD Bio Company Profile
YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.
Further Reading
- Five stocks we like better than YD Bio
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for YD Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for YD Bio and related companies with MarketBeat.com's FREE daily email newsletter.
